Device Trial Radar · NCT04122248
M6-C Post Approval Study (PAS)
Last checked: Nov 20, 2026Latest source record: Jul 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
152
Actual
Start
Nov 30, 2019
Primary completion
Jun 30, 2026
Study completion Jun 30, 2026
Sponsor
- Lead sponsor
- Spinal KineticsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 10, 2019
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years, up to 68 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The M6-C Post Approval Study is a long term follow-up study of subjects previously enrolled and treated in the M6-C Artificial Cervical Disc IDE Study.
Conditions
- Cervical Degenerative Disc Disease
- Cervical Radiculopathy
- Cervical Spinal Cord Compression
- Cervical Disc Herniation
Interventions
standard radiographic imagingOther
standard radiographic imaging
cervical total disc replacementDevice
Artificial disc replacement (ADR) in the cervical spine is a minimally invasive procedure that involves removing diseased disc tissue and replacing it with an artificial disc. The artificial disc is designed to preserve the spine\'s natural motion while remaining securely attached to the surrounding vertebral bones. The goal of ADR is to help preserve the motion of the cervical spine or spinal segment after surgery, which can improve the quality of life for patients.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall subject successTime frame: 10 year follow-up
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
Desert Institute for Spine Care
Phoenix, Arizona
The CORE Institute
Sun City West, Arizona
Spine MD
Beverly Hills, California
18 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.